Industries de la santé
26 Avril 2013
COPENHAGEN, DENMARK – April 25, 2013 - Novozymes, the world leader in bioinnovation and industrial enzymes, today reported a first quarter of 2013 in line with expectations. Organic sales growth was 5% (4% DKK, 5% LCY) compared with Q1 2012. EBIT grew by 4%, and the EBIT margin was 24.9% – on par with the first quarter of 2012. The outlook for full-year 2013 sales growth in DKK... |Plus d'articles...
- Lilly France annonce la nomination d’Eric Baseilhac comme Directeur Corporate Affairs
- DE EMBO Press Office À Vous Sequencing tracks animal-to-human transmission of bacterial pathogens
- Metal Stents Are Effective Treatment for Blocked Bile Ducts
- Sex Between Monogamous Heterosexuals Rarely Source of Hepatitis C Infection